Clinical Challenges: BTK Inhibitors in Waldenstrom Macroglobulinemia

This class, with the only drugs ever approved for this rare blood cancer, has been a game changer

Related Keywords

Melbourne ,Victoria ,Australia ,Japan ,Massachusetts ,United States ,Japanese ,Constantine Tam ,Mike Bassett ,Peter Maccallum Cancer Centre ,Ibrutinib ,Waldenstrom Macroglobulinemia ,Zanubrutinib ,Atrial Fibrillation ,Waldenström Macroglobulinemia ,